Comorbidities in Iranian Obese Psoriatic Patients Compared With Non-Obese Patients

• Main Authors: Omid Zargari, Seyyede Zeinab Azimi, Tara Barat, Vahide Lajevardi, Ehsan Kazemnezhad, Mohammad Shahidi Dadras
• Format: Article
• Language: English
• Published: Tehran University of Medical Sciences 2019-07-01
• Series: Acta Medica Iranica
• Subjects: Psoriasis; Obesity; Metabolic syndrome; Comorbidity
• Online Access: http://acta.tums.ac.ir/index.php/acta/article/view/7532

Psoriasis is a common chronic inflammatory skin disease, which is gradually being recognized as a systemic inflammatory disorder. Psoriasis and obesity are strongly linked, but there is not enough data whether obese psoriatic patients present differently from non-obese psoriatic patients. To compare the phenotype, clinical features, severity, baseline comorbidities and laboratory findings among psoriatic patients with/without obesity all the psoriatic patients, from three centers, who were receiving systemic therapy were included in the study. Patients were divided into two groups: those with obesity and those without obesity. We included 497 patients: 154 (31%) patients were obese and 343 (69%) were non-obese. Obese patients had more comorbidities, particularly hyperlipidemia, followed by hypertension and diabetes. Fasting blood sugar and serum lipids were significantly higher among obese subjects. Given the differences between obese patients and non-obese patients, the former group should be followed and managed more closely and with specific attention..